ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 82 filers reported holding ADAMAS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $4,332,000 | -54.8% | 247,683 | -54.8% | 0.05% | -53.2% |
| Q1 2017 | $9,584,000 | +3.5% | 547,683 | 0.0% | 0.11% | +14.4% |
| Q4 2016 | $9,256,000 | +3.0% | 547,683 | 0.0% | 0.10% | +10.2% |
| Q3 2016 | $8,987,000 | +8.4% | 547,683 | 0.0% | 0.09% | -4.3% |
| Q2 2016 | $8,292,000 | +4.7% | 547,683 | 0.0% | 0.09% | +12.2% |
| Q1 2016 | $7,919,000 | -48.9% | 547,683 | 0.0% | 0.08% | -45.3% |
| Q4 2015 | $15,510,000 | +69.2% | 547,683 | 0.0% | 0.15% | +78.6% |
| Q3 2015 | $9,168,000 | -36.2% | 547,683 | 0.0% | 0.08% | -14.3% |
| Q2 2015 | $14,360,000 | +49.9% | 547,683 | 0.0% | 0.10% | +40.0% |
| Q1 2015 | $9,579,000 | +0.7% | 547,683 | 0.0% | 0.07% | -2.8% |
| Q4 2014 | $9,513,000 | -6.7% | 547,683 | 0.0% | 0.07% | -12.2% |
| Q3 2014 | $10,198,000 | +1.9% | 547,683 | 0.0% | 0.08% | +2.5% |
| Q2 2014 | $10,012,000 | – | 547,683 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |